DIHP Among Ex-US Broad ETFs
End-of-day Nov 17, 2026 · 173 Ex-US broad ETFs by 1M
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −1.0% | −2.5% | −2.3% | −6.1% | +6.8% | +9.2% | +51.7% | — | — | +46.2% |
| Peer average | −1.6% | −3.2% | −3.0% | −6.8% | +6.5% | +9.5% | +62.4% | +43.4% | +130.0% | — |
| S&P 500 · VOO | −1.0% | −2.4% | −4.5% | −4.5% | +8.3% | +10.2% | +72.7% | +68.0% | +305.1% | — |
$40 of every $1,000 in DIHP is Roche
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | ROP.SWRoche AG | Healthcare | 3.98% | $397.69 | 532K | $259.6M |
| 2 | ASMLASML | Technology | 3.09% | $308.81 | 143K | $201.6M |
| 3 | NESN.SWNestle | Consumer Defensive | 2.14% | $213.88 | 1.3M | $139.6M |
| 4 | 6758.TSony Group | Technology | 2.00% | $200.22 | 4.8M | $130.7M |
| 5 | BHP.AXBHP Group | Basic Materials | 1.50% | $149.53 | 2.5M | $97.6M |
| 6 | NVSNovartis AG | Healthcare | 1.44% | $144.30 | 588K | $94.2M |
| 7 | 6098.TRecruit | Communication Services | 1.32% | $132.10 | 794K | $86.2M |
| 8 | 8035.TTokyo Electron | Technology | 1.16% | $115.83 | 1.4M | $75.6M |
| 9 | BPBP | Energy | 1.09% | $109.02 | 1.6M | $71.2M |
| 10 | NOVO-B.CONovo Nordisk A/S | Healthcare | 1.08% | $107.82 | 1.7M | $70.4M |
| 11 | 6857.TAdvantest | Technology | 1.07% | $106.77 | 409K | $69.7M |
| 12 | SAF.PASafran | Industrials | 1.06% | $106.36 | 204K | $69.4M |
| 13 | DTE.DEDeutsche Telekom AG | Communication Services | 1.03% | $102.91 | 2.3M | $67.2M |
| 14 | ULUnilever | Consumer Defensive | 1.02% | $102.00 | 997K | $66.6M |
| 15 | GSK.LGSK | Healthcare | 1.01% | $101.07 | 2.6M | $66.0M |
of the $665B in 176 Ex-US broad ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | ROP.SW | Roche AG | 3.98% |
| 2 | ASML | ASML | 3.09% |
| 3 | NESN.SW | Nestle | 2.14% |
| 4 | 6758.T | Sony Group | 2.00% |
| 5 | BHP.AX | BHP Group | 1.50% |
| 6 | NVS | Novartis AG | 1.44% |
| 7 | 6098.T | Recruit | 1.32% |
| 8 | 8035.T | Tokyo Electron | 1.16% |
| 9 | BP | BP | 1.09% |
| 10 | NOVO-B.CO | Novo Nordisk A/S | 1.08% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 22, 2026 | Sep 24, 2026 | $0.16 |
| Jun 23, 2026 | Jun 25, 2026 | $0.29 |
| Mar 24, 2026 | Mar 26, 2026 | $0.13 |
| Dec 16, 2025 | Dec 18, 2025 | $0.12 |
| Sep 23, 2025 | Sep 25, 2025 | $0.13 |
| Jun 24, 2025 | Jun 26, 2025 | $0.31 |
| Mar 25, 2025 | Mar 27, 2025 | $0.0810 |
| Dec 17, 2024 | Dec 19, 2024 | $0.14 |
| Sep 17, 2024 | Sep 19, 2024 | $0.10 |
| Jun 18, 2024 | Jun 20, 2024 | $0.29 |
| Mar 19, 2024 | Mar 22, 2024 | $0.0516 |
| Dec 19, 2023 | Dec 22, 2023 | $0.12 |